| abstract |
The invention relates to quinoline / quinoxaline compounds that inhibit platelet-derived tyrosine kinase and / or lck tyrosine kinase, pharmaceutical compositions comprising the compounds, and their use in medicine for the treatment of patients suffering from or predisposed to disorders / conditions including cellular alterations, proliferation, production of an intercellular substance or release of a mediator and / or activation and proliferation of T cells. a |